Research ArticleInfectious Disease

A probiotic yeast-based immunotherapy against Clostridioides difficile infection

See allHide authors and affiliations

Science Translational Medicine  28 Oct 2020:
Vol. 12, Issue 567, eaax4905
DOI: 10.1126/scitranslmed.aax4905

Article Information

vol. 12 no. 567

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication April 12, 2019
  • Resubmitted February 12, 2020
  • Accepted for publication October 7, 2020
  • .

Author Information

  1. Kevin Chen1,
  2. Yixuan Zhu2,*,
  3. Yongrong Zhang1,
  4. Therwa Hamza1,
  5. Hua Yu3,
  6. Ashley Saint Fleur1,
  7. James Galen2,
  8. Zhiyong Yang3 and
  9. Hanping Feng1,
  1. 1Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.
  2. 2Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  3. 3FZata Inc., Halethorpe, MD 21227, USA.
  1. Corresponding author. Email: hfeng{at}umaryland.edu
  • * Present address: GeneCopoeia Inc., Rockville, MD 20850, USA.

Altmetric

Article usage

Article usage: October 2020 to June 2021

AbstractFullPdf
Oct 20203848564231
Nov 20202953543272
Dec 2020360172101
Jan 202137511851
Feb 20212083637
Mar 20212737236
Apr 20211824528
May 20211585827
Jun 20211031612

Stay Connected to Science Translational Medicine